{"schema_version":"1","generated_at":"2026-11-11T20:05:13.262Z","data_as_of":null,"url":"https://www.findmykol.com/kol/david-hyslop","json_url":"https://www.findmykol.com/kol/david-hyslop/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"david-hyslop","name":"David Hyslop","credential":"MD","specialty":"Infectious Disease","specialty_raw":"Infectious Disease","therapeutic_area":"Infectious Disease","therapeutic_areas":["Infectious Disease"],"institution":"SpringWorks Therapeutics","institution_url":"https://www.findmykol.com/institution/springworks-therapeutics","city":"Avon","state":"IN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1134438492","openalex":"A5021501902"},"summary":"David Hyslop is an Infectious Disease physician affiliated with SpringWorks Therapeutics. OpenAlex indexes 16 publications with 515 citations (h-index 8).","overview":null,"focus":{"indications":[],"research_topics":["Infectious Disease"]},"scholarship":{"works_count":16,"cited_by_count":515,"h_index":8,"latest_activity_year":2024,"source":"works"},"publications":{"total":16,"shown":5,"withheld":11,"matched_by":"OpenAlex author record","recent":[{"title":"Onset and resolution of ovarian toxicity with nirogacestat treatment in females with desmoid tumors: Updated safety analyses from the DeFi phase 3 study","year":2024,"journal":"Cancer","source_url":"https://doi.org/10.1002/cncr.35324","status":"verified"},{"title":"Monitoring ovarian function in oncology studies: Results and insights from the DeFi phase 3 study of nirogacestat in desmoid tumor.","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.11520","status":"verified"},{"title":"Infections in baricitinib clinical trials for patients with active rheumatoid arthritis","year":2020,"journal":"Annals of the Rheumatic Diseases","source_url":"https://doi.org/10.1136/annrheumdis-2019-216852","status":"verified"},{"title":"Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment","year":2018,"journal":"The Journal of Rheumatology","source_url":"https://doi.org/10.3899/jrheum.171361","status":"verified"},{"title":"FRI0092 Effects of baricitinib on haemoglobin and related laboratory parameters in rheumatoid arthritis patients","year":2017,"journal":"Annals of the Rheumatic Diseases","source_url":"https://doi.org/10.1136/annrheumdis-2017-eular.1335","status":"verified"}],"source":"works"},"contact":{"address_1":"6013 YELLOW BIRCH CT","city":"Avon","state":"IN","zip":"461238235","phone":"317-838-7096","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1134438492","source":"identity"},"similar":[{"name":"Uchenna Iloeje","slug":"uchenna-iloeje","institution":"SpringWorks Therapeutics","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/uchenna-iloeje","json_url":"https://www.findmykol.com/kol/uchenna-iloeje/profile.json"},{"name":"Thomas Walsh","slug":"thomas-walsh","institution":"Cornell University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/thomas-walsh","json_url":"https://www.findmykol.com/kol/thomas-walsh/profile.json"},{"name":"Douglas Richman","slug":"douglas-richman","institution":"University of California San Diego","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/douglas-richman","json_url":"https://www.findmykol.com/kol/douglas-richman/profile.json"},{"name":"Henry Masur","slug":"henry-masur","institution":"National Institutes of Health","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/henry-masur","json_url":"https://www.findmykol.com/kol/henry-masur/profile.json"},{"name":"Vance Fowler","slug":"vance-fowler","institution":"Duke University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/vance-fowler","json_url":"https://www.findmykol.com/kol/vance-fowler/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":11}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2010-10-04","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}